The company just completed a small double-blind placebo-controlled study that reduced amyloid beta and tau oligomers in human subjects. These oligomers are highly toxic proteins that cause Alzheimer's and other dementias, and are targeted by many pharmaceutical companies.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
